To artificially replicate the pathophysiological features of AD in NHP, several strategies have also been tested such as the induction of insulin deficiency using streptozotocin245,246, the intraventricular injection of synthetic amyloid-beta oligomers247, or the injection into the EC of a viral vector expressing a double tau mutation248. This evidence concerns the gene MAPT and Alzheimer disease.